Dopamine–H2S Axis Drives Dual Mitophagy in Ischemia–Reperfusion Injury

Study Background and Research Question

Cerebral ischemia–reperfusion injury (CIRI) is a major clinical challenge following ischemic stroke, responsible for significant neuronal loss and long-term neurological deficits worldwide. The restoration of blood flow, although essential, paradoxically triggers a surge in reactive oxygen species (ROS), exacerbating mitochondrial dysfunction, apoptosis, and overall neuronal damage. Targeting oxidative stress and mitochondrial quality control is thus a central focus in neuroprotection research. The reference study (Zhou et al., 2025) investigates whether environmental enrichment (EE)—a non-pharmacological intervention known to promote neural plasticity—can mitigate CIRI through modulation of mitochondrial dynamics and cellular stress pathways. The central research question: How does EE confer neuroprotection at the molecular level, especially regarding mitochondrial quality control mechanisms?

Key Innovation from the Reference Study

The study’s key innovation lies in elucidating a previously uncharacterized neuroprotective cascade linking enriched environmental cues to dual-pathway mitophagy activation through the dopamine–hydrogen sulfide (H₂S) axis. Specifically, the authors demonstrate that EE enhances endogenous H₂S biosynthesis via dopaminergic signaling, which coordinates both canonical (PINK1/parkin) and non-canonical (HIF-1α/BNIP3L) mitophagy pathways. This dual activation facilitates the selective clearance of dysfunctional mitochondria, thereby preserving mitochondrial integrity and neuronal survival during CIRI. The integration of behavioral, histological, and multi-omics analyses provides robust evidence for this complex signaling network.

Methods and Experimental Design Insights

The research combined in vivo and in vitro approaches to dissect the molecular underpinnings of EE’s neuroprotective effects. The primary animal model was the middle cerebral artery occlusion (MCAO) mouse, a well-established paradigm for mimicking human ischemic stroke and reperfusion. In parallel, oxygen–glucose deprivation/reoxygenation (OGD/R) was induced in SH-SY5Y neuroblastoma cells to recapitulate neuronal injury in vitro.

Key interventions included pharmacological inhibitors to block H₂S synthesis, HIF-1α activity, and mitophagy, allowing the authors to systematically dissect the contribution of each pathway. Behavioral outcomes (neurological scoring), histological analyses (TTC staining for infarct volume, TUNEL for apoptosis), and molecular assays (Western blotting, immunofluorescence, co-immunoprecipitation) were complemented by transmission electron microscopy to visualize mitophagic structures. Transcriptomic profiling and biochemical quantification of oxidative stress markers (MDA, MnSOD, glutathione) provided further mechanistic insights.

Core Findings and Why They Matter

Behavioral and molecular assessments revealed that EE markedly improved neurological recovery after CIRI, as evidenced by reduced infarct volume and suppressed neuronal apoptosis. Critically, EE also attenuated oxidative damage: malondialdehyde (MDA) levels, a marker of lipid peroxidation, were decreased, while antioxidant defenses (MnSOD, glutathione) were enhanced (Zhou et al., 2025).

At the mechanistic level, the study provides strong evidence that EE upregulates H₂S production through dopamine-induced calcium influx, activating calmodulin-dependent cystathionine β-synthase and γ-lyase. Increased H₂S, in turn, triggers two mitophagy routes: the canonical PINK1/parkin pathway and the HIF-1α/BNIP3L axis. Both are essential for the removal of damaged mitochondria. Pharmacological blockade of H₂S synthesis or HIF-1α dampened mitophagy and abolished EE’s mitochondrial protective effects, establishing H₂S as a central mediator. These findings position the inhibition of hypoxia-inducible factor 1 transcriptional activity and the restoration of mitochondrial homeostasis as promising targets for reducing CIRI severity.

Comparison with Existing Internal Articles

Prior internal resources have emphasized the importance of hypoxia signaling and mitochondrial quality control in oncology and neurobiology. For example, the review "YC-1: Unraveling Hypoxia Signaling and Neuroinflammation" details how YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol, a dual HIF-1α inhibitor and soluble guanylyl cyclase activator, modulates hypoxia and cGMP pathways in both cancer and neuroinflammatory contexts. Similarly, "YC-1: sGC Activator & HIF-1α Inhibitor for Cancer and Hypoxia" discusses how targeting HIF-1α and mitochondrial pathways can influence tumor angiogenesis and apoptosis.

What distinguishes the present study is its focus on the interconnectedness between environmental factors, neurotransmitter signaling, gasotransmitter biosynthesis, and dual-pathway mitophagy in the context of acute neuronal injury. While internal articles primarily address cancer biology and chronic hypoxia, this work extends the conceptual framework to acute ischemic events, providing a unique bridge between mitochondrial research in oncology and neuroprotection.

Protocol Parameters

• MCAO mouse modeling: Induce focal cerebral ischemia by transient middle cerebral artery occlusion, followed by reperfusion; monitor neurological deficits and infarct volume.
• Environmental enrichment (EE): Expose animals to complex, stimulus-rich cages (toys, tunnels, running wheels) starting post-surgery and continuing throughout recovery period.
• OGD/R neuronal injury: Subject SH-SY5Y cells to oxygen–glucose deprivation for a defined period (e.g., 1–2 h), followed by reoxygenation; assess cell viability and mitophagy markers.
• Pharmacological interventions: Administer H₂S synthesis inhibitors (e.g., aminooxyacetic acid), HIF-1α inhibitors (such as YC-1 where appropriate), and mitophagy pathway modulators prior to or during reperfusion phases to dissect pathway contributions.
• Mitophagy assessment: Combine transmission electron microscopy with immunofluorescent labeling (LC3B/parkin colocalization) for direct visualization of mitophagic vesicles.
• Oxidative stress quantification: Measure MDA, MnSOD, and glutathione in tissue lysates to track redox status.

Limitations and Transferability

While the study provides compelling evidence for the dopamine–H₂S–mitophagy axis in CIRI, several limitations should be noted. First, most mechanistic insights derive from rodent models and immortalized cell lines; translational relevance to human stroke patients requires further validation. Second, the specific temporal dynamics and dose-responsiveness of EE and pharmacological interventions were not exhaustively mapped. Finally, the interplay between canonical and non-canonical mitophagy pathways may differ in chronic neurodegenerative conditions, limiting direct extrapolation.

Research Support Resources

For researchers aiming to dissect the role of HIF-1α in mitochondrial quality control, the small molecule YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol (SKU B7641) provides a high-purity, validated HIF-1α inhibitor and soluble guanylyl cyclase activator suitable for in vitro and in vivo research workflows. Its documented utility in inhibition of hypoxia-inducible factor 1 transcriptional activity and tumor angiogenesis inhibition makes it a versatile tool for apoptosis and cancer biology research, as well as for interrogating the HIF-1α/BNIP3L mitophagy axis in neurological models. Further details on usage and storage can be found in the APExBIO product dossier.